What is HUTCHMED China Ltd (HCM)?
HUTCHMED China Ltd is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies and immunotherapies for cancer and autoimmune diseases. The company integrates research and development efforts with clinical development to advance novel drug candidates. HUTCHMED China Ltd operates a portfolio of proprietary compounds and collaborates with global partners to expand its therapeutic pipeline. Its activities encompass early-stage research, clinical trials, and regulatory approvals, aiming to address unmet medical needs. The company’s approach combines scientific innovation with commercial capabilities to bring new treatments to patients primarily in China and other international markets. HUTCHMED China Ltd contributes to advancements in precision medicine and oncology therapeutics.
HUTCHMED China Ltd Stock Price Today: Live Overview
The price today is shaped by trading session dynamics, with CVS Group PLC at £2.1225. Its intraday range lies between £2.0175 and £2.0375, marking a daily change of -0.9816%.
FAQ: HUTCHMED China Ltd (HCM)
What is the current price of HCM stock?
HUTCHMED China Ltd's current price is £2.1225.
Does HCM pay dividends?
HUTCHMED China Ltd does not pay dividends.
Does HCM have a formal corporate presence or regional headquarters in the UAE?
HUTCHMED China Ltd has an official regional office in the UAE located in DIFC.
What is HCM best known for?
HUTCHMED China Ltd is most famous for its biopharmaceutical research and development.
What assets are typically shown together with HCM?
Commonly shown alongside HCM: iShares Global Consumer Discretionary ETF, iShares Global Consumer Discretionary ETF, LSE
Latest shares articles



